Ibex Investors’s Intercure INCR Stock Holding History

Ibex Investors’s Portfolio INCR Stock Details INCR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-377,255	Closed	-$2.77M	–	14
2025 Q2	$2.77M	Hold	377,255	–	–	2.84%	6
2025 Q1	$2.64M	Hold	377,255	–	–	3.51%	5
2024 Q4	$3.02M	Sell	377,255 -677	-0.2%	-$5.33K	2.6%	8
2024 Q3	$3.8M	Hold	377,932	–	–	4.35%	7
2024 Q2	$3.8M	Hold	377,932	–	–	3.92%	6
2024 Q1	$5.12M	Hold	377,932	–	–	6.6%	6
2023 Q4	$2.44M	Sell	377,932 -3,323	-0.9%	-$20.3K	2.95%	7
2023 Q3	$2.99M	Buy	381,255 +700	+0.2%	+$5.59K	3.4%	6
2023 Q2	$3.23M	Hold	380,555	–	–	4%	5
2023 Q1	$3.88M	Hold	380,555	–	–	5.75%	4
2022 Q4	$6.28M	Buy	380,555 +3,300	+0.9%	+$76.4K	4.2%	8
2022 Q3	$8.49M	Hold	377,255	–	–	4.36%	8
2022 Q2	$10.9M	Hold	377,255	–	–	6.86%	6
2022 Q1	$13.4M	Hold	377,255	–	–	0.59%	6
2021 Q4	$12.2M	Buy	377,255 +106,044	+39%	+$3.8M	4.1%	7
2021 Q3	$9.4M	Buy	+271,211	New	+$9.73M	1.99%	8

Other funds holding INCR

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return

AdvisorShares Investments Bethesda, Maryland $828M AUM 37.72% 1-Year Est. Return

MCM

Moore Capital Management New York $6.74B AUM 45.87% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

StoneX Group New York $2.48B AUM 33.54% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

RWM

Revisor Wealth Management Akron, Ohio $416M AUM 25.24% 1-Year Est. Return

Ibex Investors's INCR Position: Q3 2025 in Review

Ibex Investors sold out of Intercure (INCR) in Q3 2025, closing a stake of 377,255 shares — an estimated $2.77M sold.

Ibex Investors first reported a position in INCR in Q3 2021 and held it in 16 quarters. The position peaked at $13.4M in Q1 2022. 22 funds tracked by Wall St. Rank hold INCR as of Q3 2025.

Ibex Investors reported no remaining Intercure position as of Q3 2025 after selling out during the quarter.
Ibex Investors sold 377,255 Intercure shares in Q3 2025, an estimated $2.77M.
Ibex Investors first reported a position in Intercure in Q3 2021 and held it in 16 quarters.
Ibex Investors's Intercure position peaked at $13.4M in Q1 2022.
22 funds tracked by Wall St. Rank held Intercure as of Q3 2025.

Based on Ibex Investors's 13F filing for Q3 2025, filed 6 Nov 2025.